首页> 美国卫生研究院文献>Disease Markers >Elevated IL-1α and CXCL10 Serum Levels Occur in Patients with Homozygous Sickle Cell Disease and a History of Acute Splenic Sequestration
【2h】

Elevated IL-1α and CXCL10 Serum Levels Occur in Patients with Homozygous Sickle Cell Disease and a History of Acute Splenic Sequestration

机译:纯合镰状细胞病患者的IL-1α和CXCL10血清水平升高并有急性脾隔离病史

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute splenic sequestration (ASS) and chronic hypersplenism are common features of homozygous sickle cell (SS) disease in the first 5 years of life affecting one-third of subjects in the Jamaican Cohort Study. The risk factors are largely unknown and the current study explores a possible role of genetic factors. We have explored these in subjects who received splenectomy in the management of ASS (n=8) or chronic hypersplenism (n=9) along with age, gender, and genotype matched controls using Luminex Technology to assess 42 human cytokines/chemokines, including IL-1α and CXCL10 (IP-10). Levels of IL-1α (p=0.008) and CXCL10 (p=0.009) were significantly elevated in patients treated by splenectomy compared with the control group. Levels of IL-1α were significantly higher in those with a history of ASS compared with matched normal controls (p=0.028) but not in those treated for hypersplenism (p=0.093). Furthermore, several significant differences were found in the median ratios of some cytokine biomarkers between the splenectomized group and the normal controls. These observations are consistent with acute splenic sequestration having a distinct phenotype which may be helpful in predicting those at risk of this complication and suggest that the mechanism of these differences merit further study.
机译:在牙买加队列研究中,急性脾隔离症(ASS)和慢性脾功能亢进症是生命最初5年中纯合镰状细胞(SS)疾病的常见特征,影响了三分之一的受试者。危险因素很大程度上未知,当前的研究探讨了遗传因素的可能作用。我们在使用Luminex技术评估42种人类细胞因子/趋化因子(包括IL)的受试者中,对接受脾切除术的ASS(n = 8)或慢性脾功能亢进症(n = 9)以及年龄,性别和基因型匹配对照的受试者进行了研究。 -1α和CXCL10(IP-10)。与对照组相比,脾切除术患者的IL-1α(p = 0.008)和CXCL10(p = 0.009)水平显着升高。与配对的正常对照组相比,具有ASS病史的患者中IL-1α的水平显着更高(p = 0.028),但对于脾功能亢进的患者则没有(p = 0.093)。此外,在脾切除组和正常对照组之间,一些细胞因子生物标志物的中位数比率发现了几个显着差异。这些观察结果与具有独特表型的急性脾隔离症相吻合,这可能有助于预测有此并发症风险的人,并建议这些差异的机制值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号